Evidence map›Paper›PMID 22128055›Full record

ArticleGenetic epidemiology2011

Incorporating biological information into association studies of sequencing data.

Gary K Chen, Gary Chen, Peng Wei, Anita L DeStefano

Erratum issuedAbstract read
In one paragraph

Article in Genetic epidemiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: a multilevel approach.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2013
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

  • Erratum issued
    Chen, Gary [corrected to Chen, Gary K]
5 · Who and what money

Authors and funding

4 authors.

Gary K ChenDivision of Biostatistics, Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
Gary Chen
Peng Wei
Anita L DeStefano

Funding

EPIDEMIOLOGY OF DEMENTIA IN THE FRAMINGHAM STUDYR01AG008122 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, SESHADRI, SUDHA · 1989 to 2015
$14.4M
GENETIC ANALYSIS OF COMMON DISEASES: AN EVALUATIONR01GM031575 · NIGMS · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI ALMASY, LAURA A. · 1985 to 2016
$7.8M
Collaborative GWAS of Dementia, AD and related MRI and Cognitive EndophenotypesR01AG033193 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SESHADRI, SUDHA · 2009 to 2016
$4.4M
Methods for Pathway Modeling with Application to FolateR01ES019876 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMAS, DUNCAN C. · 2010 to 2014
$2.9M
Statistical Methods for Finding Missing HeritabilityR01HL106034 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI XIONG, MOMIAO · 2011 to 2014
$1.5M
Neurotrophic Factors: Genetic Variation and Serum Levels in Brain AgingR01AG031287 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SESHADRI, SUDHA · 2009 to 2010
$1.2M
HIERARCHICAL MODELING OF INTERACTIONS IN GENOME-WIDE AND PATHWAY-BASED STUDIESR01ES016813 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CONTI, DAVID V · 2009 to 2010
$1.1M
DESIGN AND ANALYSIS OF GENOME-WIDE ASSOCIATION STUDIESU01ES015090 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMAS, DUNCAN C. · 2006 to 2008
$927k
NHLBI NIH HHS R01 HL106034NIA NIH HHS R01 AG008122NIA NIH HHS R01 AG031287NIA NIH HHS R01 AG031287-02NIA NIH HHS R01 AG033193NIA NIH HHS R01 AG033193-03NIEHS NIH HHS R01 ES015090NIEHS NIH HHS R01 ES016813NIEHS NIH HHS R01 ES019876NIEHS NIH HHS U01 ES015090NIGMS NIH HHS R01 GM031575
6 · The paper itself

Abstract

We summarize the methodological contributions from Group 3 of Genetic Analysis Workshop 17 (GAW17). The overarching goal of these methods was the evaluation and enhancement of state-of-the-art approaches in integration of biological knowledge into association studies of rare variants. We found that methods loosely fell into three major categories: (1) hypothesis testing of index scores based on aggregating rare variants at the gene level, (2) variable selection techniques that incorporate biological prior information, and (3) novel approaches that integrate external (i.e., not provided by GAW17) prior information, such as pathway and single-nucleotide polymorphism (SNP) annotations. Commonalities among the findings from these contributions are that gene-based analysis of rare variants is advantageous to single-SNP analysis and that the minor allele frequency threshold to identify rare variants may influence power and thus needs to be carefully considered. A consistent increase in power was also identified by considering only nonsynonymous SNPs in the analyses. Overall, we found that no single method had an appreciable advantage over the other methods. However, methods that carried out sensitivity analyses by comparing biologically informative to noninformative prior probabilities demonstrated that integrating biological knowledge into statistical analyses always, at the least, enabled subtle improvements in the performance of any statistical method applied to these simulated data. Although these statistical improvements reflect the simulation model assumed for GAW17, our hope is that the simulation models provide a reasonable representation of the underlying biology and that these methods can thus be of utility in real data.

Indexed as

HumansModels, GeneticModels, StatisticalMolecular EpidemiologyPolymorphism, Single NucleotideSequence Analysis

Identifiers

PMID22128055
PMCPMC3635488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.